In November 2018, the FDA issued a recall of Losartan after detecting trace amounts of the probable human carcinogen N-nitrosodiethylamine (NDEA). This is the third blood pressure drug to have been recalled due to possible cancer risk.
Many patients that were on Valsartan were switched over to Losartan after Valsartan was recalled in July 2018. However, these Losartan users are still at risk for contamination. Did you or a loved one contract cancer after taking a “Sartan” blood pressure medication drug?
Losartan Recall Lawsuit: Case Quick Facts
The Problem: Losartan and Cancer
Losartan is indicated for the treatment of hypertension. The brand name, Cozaar, was approved by the FDA in 1995 and the generic, Losartan, was approved in April 2010. The recall involves one lot of Losartan Potassium Hydrochlorothiazide Tablets, USP 100mg/25mg to the consumer level. It was recalled due to the trace amount of N-nitrosodiethylamine (NDEA), an impurity that has been classified as a probable human carcinogen by the International Agency for Research on Cancer.
Which Losartan Pills were Recalled?
- Losartan Potassium Hydrochlorothiazide
- 100mg/25mg tablets in 1000-count plastic bottles
- NDC 0781-5207-10
- Lot number JB8912
- Expiration date 06/2020
The Injuries: Side Effects of Losartan
According to the Environmental Protection Agency, NDEA exposure can lead to:
- Liver Cancer
- Stomach Cancer
- Colon Cancer
- Intestinal Cancer
- Prostate Cancer
- Lower Esophageal Cancer
- Non-Hodgkin’s Lymphoma
- Multiple Myeloma
- Pancreatic Cancer
The recalled Losartan was manufactured by Zhejiang Huahai Pharmaceutical Co. Ltd. This is the same company involved in the NDMA contamination of Valsartan.
GoldenbergLaw Can Help
If you or a loved one took Losartan and was diagnosed with liver cancer, stomach cancer, colorectal cancer, intestinal cancer, esophageal cancer, prostate cancer, pancreatic cancer, non-hodgkin’s lymphoma, leukemia, or multiple myeloma, contact us.
Contact GoldenbergLaw today for a free consultation. Our consultations cost you nothing, including an obligation. The only time you’ll get a fee from us is if we win your case. Get your free consultation today and get started on your path towards justice and compensation.
FDA Losartan Recall – November 8, 2018
The FDA issued a recall for Losartan. The lot was allegedly contaminated with NDEA, a substance that is a probable human carcinogen. Losartan is the most recent recall in a series of blood pressure medication recalls by the FDA.